STXS Stock Overview
Designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Stereotaxis, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.00 |
| 52 Week High | US$3.29 |
| 52 Week Low | US$1.50 |
| Beta | 1.55 |
| 11 Month Change | 3.09% |
| 3 Month Change | 0% |
| 1 Year Change | 30.72% |
| 33 Year Change | -67.32% |
| 5 Year Change | -49.37% |
| Change since IPO | -97.44% |
Recent News & Updates
Recent updates
US$9.33 - That's What Analysts Think Stereotaxis, Inc. (NYSEMKT:STXS) Is Worth After These Results
Feb 28
Is Stereotaxis (NYSEMKT:STXS) A Risky Investment?
Jan 28
Investors Who Bought Stereotaxis (NYSEMKT:STXS) Shares Five Years Ago Are Now Up 597%
Dec 24What Kind Of Investors Own Most Of Stereotaxis, Inc. (NYSEMKT:STXS)?
Nov 19Shareholder Returns
| STXS | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 8.1% | -0.7% | -2.1% |
| 1Y | 30.7% | 22.5% | 29.7% |
Return vs Industry: STXS exceeded the US Medical Equipment industry which returned 22.4% over the past year.
Return vs Market: STXS exceeded the US Market which returned 29.6% over the past year.
Price Volatility
| STXS volatility | |
|---|---|
| STXS Average Weekly Movement | 9.3% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: STXS has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: STXS's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 122 | David Fischel | www.stereotaxis.com |
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room.
Stereotaxis, Inc. Fundamentals Summary
| STXS fundamental statistics | |
|---|---|
| Market cap | US$172.85m |
| Earnings (TTM) | -US$22.89m |
| Revenue (TTM) | US$25.14m |
6.7x
P/S Ratio-7.4x
P/E RatioIs STXS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STXS income statement (TTM) | |
|---|---|
| Revenue | US$25.14m |
| Cost of Revenue | US$11.03m |
| Gross Profit | US$14.12m |
| Other Expenses | US$37.01m |
| Earnings | -US$22.89m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.27 |
| Gross Margin | 56.14% |
| Net Profit Margin | -91.05% |
| Debt/Equity Ratio | 0% |
How did STXS perform over the long term?
See historical performance and comparison